Moderna gets U.S. contract to develop bird flu vaccine
The government awarded a $176 million contract to Moderna to develop an mRNA-based vaccine to protect people from bird flu, said Health Secretary Xavier Becerra on Tuesday. Public health officials say the risk to the general population was low from the H5N1 avian flu virus, and there were no immediate plans to use the vaccine.